Published November 4, 2025
| Version v1
Journal article
Open
Role of microRNA-9-5p as a diagnostic biomarker of acute stroke
Authors/Creators
- 1. Mustansiriyah University, Baghdad, Iraq
Description
Stroke is the second leading cause of death worldwide. MicroRNA-9-5p has been reported to be upregulated in ischemic stroke; however, no previous study has explored its expression in hemorrhagic stroke. The objective of this study was to investigate microRNA-9-5p as a biomarker to differentiate between ischemic and hemorrhagic stroke. This was a case–control study. It was found that microRNA-9-5p was upregulated in both ischemic stroke (IS) and hemorrhagic stroke (HS) compared to controls (p < 0.0001). However, no significant difference was observed between the IS and HS groups (p > 0.9999). Moreover, microRNA-9-5p could distinguish IS and HS from controls with AUC = 0.9225 and AUC = 0.9245, respectively. However, it could not differentiate IS from HS (AUC = 0.592). There was also no significant correlation between microRNA-9-5p expression fold and either IL-6 or CRP. In conclusion, microRNA-9-5p was upregulated in both IS and HS and may serve as a biomarker to distinguish stroke patients from controls, but it cannot differentiate between stroke types.
Files
PHAR_article_171140.pdf
Files
(986.4 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:1da437c4ee50c62ca1b8fd1487f60ddc
|
868.1 kB | Preview Download |
|
md5:ed653b02c5a4dc78ee90cc3fdccf0c7b
|
118.3 kB | Preview Download |
Additional details
References
- Al-Obaidi H, Khidhair Z, Jirjees F, Barakat M, AlSalamat H, Kharaba Z, Alfoteih Y, Haddad C, Mansour S, Hallit S, Malaeb D, Hosseini H (2023) Factors associated with knowledge and awareness of stroke in the Iraqi population: a cross-sectional study. Front Neurol 14: 1144481. https://doi.org/10.3389/fneur.2023.1144481
- Alotaibi SS, Alzahrani AK, Al-Nasserullah LZ, Al-Abo-Nasser B, Alhusayni NM, Alotaiby LT, Althagafi AM, Alrawi MM, Alobiri FS, Shawani MA (2020) An overview on stroke diagnosis & management approach. Archives of Pharmacy Practice 11: 60–65.
- Alrabghi L, Alnemari R, Aloteebi R, Alshammari H, Ayyad M, Al Ibrahim M, Alotayfi M, Bugshan T, Alfaifi A, Aljuwayd H (2018) Stroke types and management. International Journal Of Community Medicine And Public Health 5: 3715. https://doi.org/10.18203/2394-6040.ijcmph20183439
- American Heart Association (2019) Correction to: An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 50: e239–e239. https://doi.org/10.1161/STR.0000000000000205
- Aref HMA, Fahmy NA, Khalil SH, Ahmed MF, ElSadek A, Abdulghani MO (2020) Role of interleukin-6 in ischemic stroke outcome. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 56: 12. https://doi.org/10.1186/s41983-019-0121-8
- Babić A, Bonifačić D, Komen V, Kovačić S, Mamić M, Vuletić V (2025) Blood Biomarkers in Ischemic Stroke Diagnostics and Treatment – Future Perspectives. Medicina 61: 514. https://doi.org/10.3390/medicina61030514
- Bejleri J, Jirström E, Donovan P, Williams DJ, Pfeiffer S (2021) Diagnostic and prognostic circulating microrna in acute stroke: a systematic and bioinformatic analysis of current evidence. Journal of Stroke 23: 162–182. https://doi.org/10.5853/jos.2020.05085
- Bernstein JE, Savla P, Dong F, Zampella B, Wiginton JGt, Miulli DE, Wacker MR, Menoni R (2018) Inflammatory Markers and Severity of Intracerebral Hemorrhage. Cureus 10: e3529. https://doi.org/10.7759/cureus.3529
- Chi L, Jiao D, Nan G, Yuan H, Shen J, Gao Y (2019) miR-9-5p attenuates ischemic stroke through targeting ERMP1-mediated endoplasmic reticulum stress. Acta histochemica 121: 151438. https://doi.org/10.1016/j.acthis.2019.08.005
- Elhag DA, Al Khodor S (2023) Exploring the potential of microRNA as a diagnostic tool for gestational diabetes. Journal of Translational Medicine 21: 392. https://doi.org/10.1186/s12967-023-04269-2
- Hashim NW, Kadhim KA, Rahmah AM (2021) Effect of human insulin and insulin analogue on some inflammatory markers and total antioxidant capacity in a sample of Iraqi type 1 diabetic children and adolescents. Al Mustansiriyah Journal of Pharmaceutical Sciences 21: 9–14. https://doi.org/10.32947/ajps.v21i2.804
- Holownia A, Wielgat P, Eljaszewicz A (2019) MicroRNA-9 and Cell Proliferation in Lipopolysaccharide and Dexamethasone-Treated Naïve and Desialylated A549 Cells Grown in Cigarette Smoke Conditioned Medium. Advances in Experimental Medicine and Biology 1113: 37–42. https://doi.org/10.1007/5584_2018_168
- Huang Y, Hou X, Wang Y, Cao Y, Zhou Y, Chen Y, Cheng H (2025) MicroRNA-9-5p Alleviates Oxidative Stress, Inflammation, and Apoptosis in Cerebral Ischemia-reperfusion Injury by Targeting NOX4 In vitro. Current Molecular Medicine. https://doi.org/10.2174/0115665240337045241210064142
- Hussein M, Magdy R (2021) MicroRNAs in central nervous system disorders: current advances in pathogenesis and treatment. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 57: 36. https://doi.org/10.1186/s41983-021-00289-1
- Ji Q, Ji Y, Peng J, Zhou X, Chen X, Zhao H, Xu T, Chen L, Xu Y (2016) Increased brain-specific MiR-9 and MiR-124 in the serum exosomes of acute ischemic stroke patients. PloS one 11: e0163645. https://doi.org/10.1371/journal.pone.0163645
- Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, Abd-Allah F, Abdelalim A, Abraha HN, Abu-Rmeileh NME, Adebayo OM, Adeoye AM, Agarwal G, Agrawal S, Aichour AN, Aichour I, Aichour MTE, Alahdab F, Ali R, Alvis-Guzman N, Anber NH, Anjomshoa M, Arabloo J, Arauz A, Ärnlöv J, Arora A, Awasthi A, Banach M, Barboza MA, Barker-Collo SL, Bärnighausen TW, Basu S, Belachew AB, Belayneh YM, Bennett DA, Bensenor IM, Bhattacharyya K, Biadgo B, Bijani A, Bikbov B, Bin Sayeed MS, Butt ZA, Cahuana-Hurtado L, Carrero JJ, Carvalho F, Castañeda-Orjuela CA, Castro F, Catalá-López F, Chaiah Y, Chiang PP-C, Choi J-YJ, Christensen H, Chu D-T, Cortinovis M, Damasceno AAM, Dandona L, Dandona R, Daryani A, Davletov K, de Courten B, De la Cruz-Góngora V, Degefa MG, Dharmaratne SD, Diaz D, Dubey M, Duken EE, Edessa D, Endres M, Faraon EJA, Farzadfar F, Fernandes E, Fischer F, Flor LS, Ganji M, Gebre AK, Gebremichael TG, Geta B, Gezae KE, Gill PS, Gnedovskaya EV, Gómez-Dantés H, Goulart AC, Grosso G, Guo Y, Gupta R, Haj-Mirzaian A, Haj-Mirzaian A, Hamidi S, Hankey GJ, Hassen HY, Hay SI, Hegazy MI, Heidari B, Herial NA, Hosseini MA, Hostiuc S, Irvani SSN, Islam SMS, Jahanmehr N, Javanbakht M, Jha RP, Jonas JB, Jozwiak JJ, Jürisson M, Kahsay A, Kalani R, Kalkonde Y, Kamil TA, Kanchan T, Karch A, Karimi N, Karimi-Sari H, Kasaeian A, Kassa TD, Kazemeini H, Kefale AT, Khader YS, Khalil IA, Khan EA, Khang Y-H, Khubchandani J, Kim D, Kim YJ, Kisa A, Kivimäki M, Koyanagi A, Krishnamurthi RK, Kumar GA, Lafranconi A, Lewington S, Li S, Lo WD, Lopez AD, Lorkowski S, Lotufo PA, Mackay MT, Majdan M, Majdzadeh R, Majeed A, Malekzadeh R, Manafi N, Mansournia MA, Mehndiratta MM, Mehta V, Mengistu G, Meretoja A, Meretoja TJ, Miazgowski B, Miazgowski T, Miller TR, Mirrakhimov EM, Mohajer B, Mohammad Y, Mohammadoo-khorasani M, Mohammed S, Mohebi F, Mokdad AH, Mokhayeri Y, Moradi G, Morawska L, Moreno Velásquez I, Mousavi SM, Muhammed OSS, Muruet W, Naderi M, Naghavi M, Naik G, Nascimento BR, Negoi RI, Nguyen CT, Nguyen LH, Nirayo YL, Norrving B, Noubiap JJ, Ofori-Asenso R, Ogbo FA, Olagunju AT, Olagunju TO, Owolabi MO, Pandian JD, Patel S, Perico N, Piradov MA, Polinder S, Postma MJ, Poustchi H, Prakash V, Qorbani M, Rafiei A, Rahim F, Rahimi K, Rahimi-Movaghar V, Rahman M, Rahman MA, Reis C, Remuzzi G, Renzaho AMN, Ricci S, Roberts NLS, Robinson SR, Roever L, Roshandel G, Sabbagh P, Safari H, Safari S, Safiri S, Sahebkar A, Salehi Zahabi S, Samy AM, Santalucia P, Santos IS, Santos JV, Santric Milicevic MM, Sartorius B, Sawant AR, Schutte AE, Sepanlou SG, Shafieesabet A, Shaikh MA, Shams-Beyranvand M, Sheikh A, Sheth KN, Shibuya K, Shigematsu M, Shin M-J, Shiue I, Siabani S, Sobaih BH, Sposato LA, Sutradhar I, Sylaja PN, Szoeke CEI, Te Ao BJ, Temsah M-H, Temsah O, Thrift AG, Tonelli M, Topor-Madry R, Tran BX, Tran KB, Truelsen TC, Tsadik AG, Ullah I, Uthman OA, Vaduganathan M, Valdez PR, Vasankari TJ, Vasanthan R, Venketasubramanian N, Vosoughi K, Vu GT, Waheed Y, Weiderpass E, Weldegwergs KG, Westerman R, Wolfe CDA, Wondafrash DZ, Xu G, Yadollahpour A, Yamada T, Yatsuya H, Yimer EM, Yonemoto N, Yousefifard M, Yu C, Zaidi Z, Zamani M, Zarghi A, Zhang Y, Zodpey S, Feigin VL, Vos T, Murray CJL (2019) Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology 18: 439–458. https://doi.org/10.1016/S1474-4422(19)30034-1
- Kadir RRA, Alwjwaj M, Bayraktutan U (2022) MicroRNA: An Emerging Predictive, Diagnostic, Prognostic and Therapeutic Strategy in Ischaemic Stroke. Cellular and Molecular Neurobiology 42: 1301–1319. https://doi.org/10.1007/s10571-020-01028-5
- Kadir RRA, Bayraktutan U (2020) Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke. Cellular and Molecular Neurobiology 40: 347–355. https://doi.org/10.1007/s10571-019-00737-w
- Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE (2014) MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage. Journal of the American Society of Hypertension 8: 368–375. https://doi.org/10.1016/j.jash.2014.03.324
- Liu H, Zhou J, Jiang W, Wang F (2021) Analysis of the diagnostic and prognostic value of miR-9-5p in carotid artery stenosis. Bosnian Journal of Basic Medical Sciences 21: 724. https://doi.org/10.17305/bjbms.2021.5545
- Liu Y, Zhang J, Han R, Liu H, Sun D, Liu X (2015) Downregulation of serum brain specific microRNA is associated with inflammation and infarct volume in acute ischemic stroke. Journal of Clinical Neuroscience 22: 291–295. https://doi.org/10.1016/j.jocn.2014.05.042
- Maida CD, Norrito RL, Rizzica S, Mazzola M, Scarantino ER, Tuttolomondo A (2024) Molecular pathogenesis of ischemic and hemorrhagic strokes: background and therapeutic approaches. International Journal of Molecular Sciences 25: 6297. https://doi.org/10.3390/ijms25126297
- Narayan RN, Parambath AK, Purayil ASUP, Sekar D (2024) microRNA-9-5p and its target nuclear factor kappa B are differentially expressed in type-2 diabetes patients. Biomedical Research and Therapy 11: 6183–6190. https://doi.org/10.15419/bmrat.v11i2.863
- Patil S, Rossi R, Jabrah D, Doyle K (2022) Detection, diagnosis and treatment of acute ischemic stroke: current and future perspectives. Frontiers in medical technology 4: 748949. https://doi.org/10.3389/fmedt.2022.748949
- Searles CD (2024) MicroRNAs and cardiovascular disease risk. Current Cardiology Reports 26: 51–60. https://doi.org/10.1007/s11886-023-02014-1
- Simats A, Liesz A (2022) Systemic inflammation after stroke: implications for post‐stroke comorbidities. EMBO Molecular Medicine 14: e16269. https://doi.org/10.15252/emmm.202216269
- Sørensen SS, Nygaard AB, Carlsen AL, Heegaard NHH, Bak M, Christensen T (2017) Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke. Biomarker Research 5: 24. https://doi.org/10.1186/s40364-017-0104-9
- Tiedt S, Prestel M, Malik R, Schieferdecker N, Duering M, Kautzky V, Stoycheva I, Böck J, Northoff BH, Klein M, Dorn F, Krohn K, Teupser D, Liesz A, Plesnila N, Holdt LM, Dichgans M (2017) RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke. Circulation Research 121: 970–980. https://doi.org/10.1161/CIRCRESAHA.117.311572
- Todoran R, Falcione SR, Clarke M, Joy T, Boghozian R, Jickling GC (2023) microRNA as a therapeutic for ischemic stroke. Neurochemistry international 163: 105487. https://doi.org/10.1016/j.neuint.2023.105487
- Wang N, Yang L, Zhang H, Lu X, Wang J, Cao Y, Chen L, Wang X, Cong L, Li J, Wang N, Liu Z, Wang L (2018) MicroRNA-9a-5p Alleviates Ischemia Injury After Focal Cerebral Ischemia of the Rat by Targeting ATG5-Mediated Autophagy. Cellular Physiology and Biochemistry 45: 78–87. https://doi.org/10.1159/000486224
- Wang Q, Wang F, Fu F, Liu J, Sun W, Chen Y (2021) Diagnostic and prognostic value of serum miR-9-5p and miR-128-3p levels in early-stage acute ischemic stroke. Clinics 76: e2958. https://doi.org/10.6061/clinics/2021/e2958
- Wang Y, Su X, Leung GHD, Ren B, Zhang Q, Xiong Z, Zhou J, Yang L, Lu G, Chan W-Y (2023) Circulating microRNAs as diagnostic biomarkers for ischemic stroke: evidence from comprehensive analysis and real-world validation. International Journal of Medical Sciences 20: 1009. https://doi.org/10.7150/ijms.83963
- Warner JJ, Harrington RA, Sacco RL, Elkind MSV (2019) Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. Stroke 50: 3331–3332. https://doi.org/10.1161/strokeaha.119.027708
- Yan Q, Sun SY, Yuan S, Wang XQ, Zhang ZC (2020) Inhibition of microRNA-9-5p and microRNA-128-3p can inhibit ischemic stroke-related cell death in vitro and in vivo. IUBMB Life 72: 2382–2390. https://doi.org/10.1002/iub.2357
- Zhang J, Chen Z, Chen H, Deng Y, Li S, Jin L (2022) Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases. Biosensors 12: 1074. https://doi.org/10.3390/bios12121074
- Zhang TX, Duan XC, Cui Y, Zhang Y, Gu M, Wang ZY, Li WY (2024) Clinical significance of miR-9-5p in NSCLC and its relationship with smoking. Frontiers in Oncology 14: 1376502. https://doi.org/10.3389/fonc.2024.1376502
- Zhu F, Wang Z, Song J, Ji Y (2024) Correlation analysis of inflammatory markers with the short-term prognosis of acute ischaemic stroke. Scientific Reports 14: 17772. https://doi.org/10.1038/s41598-024-66279-4